Beijing Kawin Technology Share-holding Co Ltd
SSE:688687

Watchlist Manager
Beijing Kawin Technology Share-holding Co Ltd Logo
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Watchlist
Price: 23 CNY 0.48% Market Closed
Market Cap: 3.9B CNY
Have any thoughts about
Beijing Kawin Technology Share-holding Co Ltd?
Write Note

Beijing Kawin Technology Share-holding Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Beijing Kawin Technology Share-holding Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Additional Paid In Capital
ÂĄ1.2B
CAGR 3-Years
32%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Additional Paid In Capital
ÂĄ81.4B
CAGR 3-Years
15%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Additional Paid In Capital
ÂĄ27.5B
CAGR 3-Years
7%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Additional Paid In Capital
ÂĄ3.3B
CAGR 3-Years
95%
CAGR 5-Years
81%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Additional Paid In Capital
ÂĄ3.5B
CAGR 3-Years
-1%
CAGR 5-Years
90%
CAGR 10-Years
N/A
No Stocks Found

Beijing Kawin Technology Share-holding Co Ltd
Glance View

Market Cap
3.9B CNY
Industry
Biotechnology

Beijing Kawin Technology Share-Holding Co., Ltd. provides biotechnology treatment solutions and medicines. The company is headquartered in Beijing, Beijing and currently employs 647 full-time employees. The company went IPO on 2021-02-08. The firm's recombinant human interferon α2b and compound glycyrrhizin drugs are applied to treat viral diseases. The firm mainly distributes its products within domestic market.

Intrinsic Value
26.97 CNY
Undervaluation 15%
Intrinsic Value
Price

See Also

What is Beijing Kawin Technology Share-holding Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
1.2B CNY

Based on the financial report for Dec 31, 2023, Beijing Kawin Technology Share-holding Co Ltd's Additional Paid In Capital amounts to 1.2B CNY.

What is Beijing Kawin Technology Share-holding Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
21%

Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Beijing Kawin Technology Share-holding Co Ltd have been 32% over the past three years , 21% over the past five years .

Back to Top